Search News

Corporate Industry Technology Medical Updates

extracorporeal ventricular assist device

Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06
Corporate
magAssist Included in List of 2022 Potential Unicorn Companies in Jiangsu Province 2022-12-15
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China 2022-11-03
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022. 2022-09-30

Tabs： membrane oxygenator, cardiac arrest, DonorLife Organ Care System, ECMO manufacturers, Fortune, left ventricular assist devices, multi-organ life support, Bridge-to-other destination therapy, Chronic heart failure, the new generation ECMO system,